DK152496C - Analogifremgangsmaade til fremstilling af i 5- eller 6-stilling med en pyridazinonring substituerede benzimidazoler eller deres fysiologisk acceptable syreadditionssalte - Google Patents
Analogifremgangsmaade til fremstilling af i 5- eller 6-stilling med en pyridazinonring substituerede benzimidazoler eller deres fysiologisk acceptable syreadditionssalteInfo
- Publication number
- DK152496C DK152496C DK354279A DK354279A DK152496C DK 152496 C DK152496 C DK 152496C DK 354279 A DK354279 A DK 354279A DK 354279 A DK354279 A DK 354279A DK 152496 C DK152496 C DK 152496C
- Authority
- DK
- Denmark
- Prior art keywords
- physially
- pyridazinon
- preparing
- acid addition
- addition salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782837161 DE2837161A1 (de) | 1978-08-25 | 1978-08-25 | Neue benzimidazole und deren verwendung |
DE2837161 | 1978-08-25 | ||
DE19792922336 DE2922336A1 (de) | 1979-06-01 | 1979-06-01 | Neue in 5- oder 6-stellung durch einen pyridazinonring substituierte benzimidazole und deren verwendung als arzneimittel |
DE2922336 | 1979-06-01 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK354279A DK354279A (da) | 1980-02-26 |
DK152496B DK152496B (da) | 1988-03-07 |
DK152496C true DK152496C (da) | 1988-07-25 |
Family
ID=25775527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK354279A DK152496C (da) | 1978-08-25 | 1979-08-24 | Analogifremgangsmaade til fremstilling af i 5- eller 6-stilling med en pyridazinonring substituerede benzimidazoler eller deres fysiologisk acceptable syreadditionssalte |
Country Status (17)
Country | Link |
---|---|
US (1) | US4361563A (nl) |
EP (1) | EP0008391B1 (nl) |
AU (1) | AU528825B2 (nl) |
BG (1) | BG60428B2 (nl) |
CA (1) | CA1134362A (nl) |
CS (1) | CS410191A3 (nl) |
DE (1) | DE2962051D1 (nl) |
DK (1) | DK152496C (nl) |
ES (2) | ES8101067A1 (nl) |
FI (1) | FI66372C (nl) |
GR (1) | GR69998B (nl) |
HK (1) | HK50585A (nl) |
IE (1) | IE48814B1 (nl) |
MX (1) | MX9202731A (nl) |
NL (1) | NL980035I2 (nl) |
PH (1) | PH17515A (nl) |
SG (1) | SG285G (nl) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4699909A (en) * | 1981-07-25 | 1987-10-13 | Dr. Karl Thomae Gmbh | Benzotriazolyl-4,5-dihydro-3(2H)-pyridazinones |
DE3129447A1 (de) * | 1981-07-25 | 1983-02-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | "neue benztriazole, ihre herstellung und ihre verwendung als arzneimittel" |
US4353905A (en) * | 1981-09-17 | 1982-10-12 | Warner-Lambert Company | Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones |
IT1172270B (it) * | 1982-06-21 | 1987-06-18 | Wellcome Found | Procedimento per la produzione di interferon |
US4734415A (en) * | 1982-08-13 | 1988-03-29 | Warner-Lambert Company | Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones |
US4717730A (en) * | 1982-12-03 | 1988-01-05 | Warner-Lambert Company | 4,5-dihydro-6-(substituted)phenyl-5-methyl-3-(2H)-pyridazinones and pharmaceutical compositions containing the compounds as active components |
US4521416A (en) * | 1983-03-22 | 1985-06-04 | Warner-Lambert Company | 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones |
GB8320005D0 (en) * | 1983-07-25 | 1983-08-24 | Fujisawa Pharmaceutical Co | Benzothiazoline derivatives |
US4591591A (en) * | 1984-03-08 | 1986-05-27 | Eli Lilly And Company | Pyridazinone derivatives as inotropic agents |
US4647564A (en) * | 1984-05-14 | 1987-03-03 | Eli Lilly And Company | Inotropic agents |
IL75122A (en) * | 1984-05-14 | 1989-02-28 | Lilly Co Eli | 3-methyl-5-(tetrahydro-6-oxopyridazin-3-yl)indoline derivatives,their preparation and use |
US4816454A (en) * | 1984-09-21 | 1989-03-28 | Cassella Aktiengesellschaft | 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use |
US4617302A (en) * | 1984-10-15 | 1986-10-14 | Eli Lilly And Company | Inotropic agents |
DE3505609A1 (de) * | 1985-02-19 | 1986-08-21 | Merck Patent Gmbh, 6100 Darmstadt | Benzimidazolyl-pyridazinone |
DE3511110A1 (de) * | 1985-03-27 | 1986-10-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue pyridazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel |
US4906630A (en) * | 1985-11-22 | 1990-03-06 | Rorer Pharmaceutical Corporation | Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds |
US4725686A (en) * | 1985-11-22 | 1988-02-16 | William H. Rorer, Inc. | Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses |
US4785101A (en) * | 1985-11-22 | 1988-11-15 | Rorer Pharmaceutical Corporation | Benzodiazinone-hydroxypyrazolyl compounds, cardiotonic compositions including the same and their uses |
US4868300A (en) * | 1985-11-22 | 1989-09-19 | Rorer Pharmaceutical Corporation | Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses |
DE3623944A1 (de) * | 1986-07-16 | 1988-02-11 | Thomae Gmbh Dr K | Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US4859672A (en) * | 1986-10-29 | 1989-08-22 | Rorer Pharmaceutical Corporation | Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone |
DE3704879A1 (de) * | 1987-02-17 | 1988-08-25 | Merck Patent Gmbh | Pyridazinonderivate |
DE3734083A1 (de) * | 1987-10-08 | 1989-04-20 | Heumann Pharma Gmbh & Co | Benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
EP0326307B1 (en) * | 1988-01-23 | 1994-08-17 | Kyowa Hakko Kogyo Co., Ltd. | Novel pyridazinone derivatives and pharmaceutical preparations containing them |
DE3805635A1 (de) * | 1988-02-24 | 1989-09-07 | Thomae Gmbh Dr K | Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica |
DE3814057A1 (de) * | 1988-04-26 | 1989-11-09 | Heumann Pharma Gmbh & Co | 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US5338743A (en) * | 1988-06-06 | 1994-08-16 | Fujisawa Pharmaceutical Co., Ltd. | New use of the adenosine antagonist |
DE68924308T2 (de) * | 1988-07-11 | 1996-04-04 | Akzo Nobel Nv | Pyridazinon-Derivate. |
DE3830054A1 (de) * | 1988-09-03 | 1990-03-15 | Boehringer Mannheim Gmbh | Phenylamide - verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
DE3908531A1 (de) * | 1989-03-16 | 1990-09-20 | Thomae Gmbh Dr K | Arzneimittel mit einer positiv inotropen wirkung, enthaltend eine synergistisch wirkende mischung, bestehend aus einem benzimidazol und einem ss-blocker, deren herstellung und deren verwendung |
DE3934436A1 (de) * | 1989-06-01 | 1991-04-18 | Thomae Gmbh Dr K | 2-hydroxy-n-propylamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US5364646A (en) * | 1990-01-10 | 1994-11-15 | Dr. Karl Thomae Gmbh | Oral pharmaceutical forms of pimobendan |
DE4001622A1 (de) * | 1990-01-20 | 1991-07-25 | Thomae Gmbh Dr K | Orale arzneimittelformen von pimobendan |
CA2060138A1 (en) * | 1991-01-29 | 1992-07-30 | Youichi Shiokawa | New use of the adenosine antagonist |
JP4548866B2 (ja) * | 1997-06-10 | 2010-09-22 | グラクソ グループ リミテッド | ベンゾイミダゾール誘導体 |
US6162804A (en) * | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
US6465484B1 (en) | 1997-09-26 | 2002-10-15 | Merck & Co., Inc. | Angiogenesis inhibitors |
EP1123703B1 (en) | 1998-10-23 | 2004-04-14 | Toray Industries, Inc. | Immunomodulatory drug composition |
TWI225488B (en) * | 1999-12-21 | 2004-12-21 | Janssen Pharmaceutica Nv | Derivatives of homopiperidinyl substituted benzimidazole analogues |
ES2298277T3 (es) * | 2000-07-31 | 2008-05-16 | Carl Ernest Alexander | Composicion y dispositivo de higiene oral personal. |
EP1406621A2 (en) * | 2001-06-26 | 2004-04-14 | Beth Israel Deaconess Medical Center | Compositions and methods for inhibiting platelet activation and thrombosis |
DE10203086A1 (de) * | 2002-01-28 | 2003-07-31 | Bayer Ag | 5-Ring Heterozyklen |
DE102004011512B4 (de) | 2004-03-08 | 2022-01-13 | Boehringer Ingelheim Vetmedica Gmbh | Pharmazeutische Zubereitung enthaltend Pimobendan |
US8980894B2 (en) * | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
EP1579862A1 (en) * | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
JP4714921B2 (ja) * | 2005-02-14 | 2011-07-06 | トーアエイヨー株式会社 | ピモベンダンの製造法及びその中間体 |
RU2385865C2 (ru) * | 2005-08-15 | 2010-04-10 | Айрм Ллк | Соединения и композиции в качестве миметиков тро |
PL1951227T3 (pl) | 2005-11-14 | 2017-09-29 | Boehringer Ingelheim Vetmedica Gmbh | Zastosowania pimobendanu do leczenia bezobjawowej(utajonej) niewydolności serca |
EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
FR2917975B1 (fr) | 2007-06-26 | 2009-10-16 | Ceva Sante Animale Sa | Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains |
MX2011005444A (es) | 2008-11-25 | 2011-06-09 | Boehringer Ingelheim Vetmed | Inhibidores de la fosfodiesterasa tipo iii (pde iii) o agentes sensibilizantes a iones de ca(2+) para el tratamiento de la cardiomiopatia hipertrofica. |
NL1037569C2 (en) * | 2009-12-18 | 2011-06-21 | Eurovet Animal Health B V | Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use. |
WO2013024036A1 (en) | 2011-08-12 | 2013-02-21 | Boehringer Ingelheim Vetmedica Gmbh | Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline |
EP2825159B1 (en) | 2012-03-15 | 2022-06-22 | Boehringer Ingelheim Vetmedica GmbH | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
WO2015007760A1 (en) | 2013-07-19 | 2015-01-22 | Boehringer Ingelheim Vetmedica Gmbh | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
EP3106150B1 (en) | 2013-12-04 | 2021-07-28 | Boehringer Ingelheim Vetmedica GmbH | Improved pharmaceutical compositions of pimobendan |
US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
CN106432095B (zh) * | 2016-09-09 | 2019-04-16 | 东南大学 | 匹莫苯丹关键中间体6-(3,4-二氨基苯基)-5-甲基-4,5-二氢哒嗪-3(2h)-酮的制备 |
CN106518850B (zh) * | 2016-11-15 | 2019-04-09 | 青岛农业大学 | 一种匹莫苯丹的化学合成方法 |
WO2022073954A1 (en) | 2020-10-08 | 2022-04-14 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan in the anaesthesia of non-human mammals |
WO2024126434A1 (en) | 2022-12-15 | 2024-06-20 | Boehringer Ingelheim Vetmedica Gmbh | Solid dispersions comprising amorphous pimobendan and one or more stabilizing polymers |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2516040C2 (de) * | 1974-06-10 | 1984-12-20 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
DE2427943C2 (de) * | 1974-06-10 | 1984-08-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
JPS5416485A (en) * | 1977-07-08 | 1979-02-07 | Yoshitomi Pharmaceut Ind Ltd | Pyridazinone derivatives and their preparation |
-
1979
- 1979-07-24 ES ES482789A patent/ES8101067A1/es not_active Expired
- 1979-07-25 GR GR59689A patent/GR69998B/el unknown
- 1979-08-01 DE DE7979102758T patent/DE2962051D1/de not_active Expired
- 1979-08-01 EP EP79102758A patent/EP0008391B1/de not_active Expired
- 1979-08-23 CA CA000334357A patent/CA1134362A/en not_active Expired
- 1979-08-23 FI FI792628A patent/FI66372C/fi not_active IP Right Cessation
- 1979-08-24 AU AU50279/79A patent/AU528825B2/en not_active Expired
- 1979-08-24 IE IE1629/79A patent/IE48814B1/en not_active IP Right Cessation
- 1979-08-24 DK DK354279A patent/DK152496C/da not_active IP Right Cessation
-
1980
- 1980-05-29 ES ES491970A patent/ES8105001A1/es not_active Expired
-
1981
- 1981-05-01 US US06/259,537 patent/US4361563A/en not_active Expired - Lifetime
- 1981-05-26 PH PH25674A patent/PH17515A/en unknown
-
1985
- 1985-01-03 SG SG2/85A patent/SG285G/en unknown
- 1985-07-04 HK HK505/85A patent/HK50585A/xx not_active IP Right Cessation
-
1991
- 1991-12-27 CS CS914101A patent/CS410191A3/cs unknown
-
1992
- 1992-06-08 MX MX9202731A patent/MX9202731A/es unknown
-
1994
- 1994-01-25 BG BG98420A patent/BG60428B2/bg unknown
-
1998
- 1998-11-19 NL NL980035C patent/NL980035I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
AU5027979A (en) | 1980-02-28 |
AU528825B2 (en) | 1983-05-12 |
IE48814B1 (en) | 1985-05-29 |
FI66372B (fi) | 1984-06-29 |
CA1134362A (en) | 1982-10-26 |
PH17515A (en) | 1984-09-13 |
ES482789A0 (es) | 1980-12-01 |
DK354279A (da) | 1980-02-26 |
BG60428B2 (bg) | 1995-03-31 |
HK50585A (en) | 1985-07-12 |
EP0008391A1 (de) | 1980-03-05 |
FI792628A (fi) | 1980-02-26 |
DK152496B (da) | 1988-03-07 |
GR69998B (nl) | 1982-07-23 |
ES491970A0 (es) | 1981-05-16 |
ES8105001A1 (es) | 1981-05-16 |
SG285G (en) | 1985-11-15 |
US4361563A (en) | 1982-11-30 |
ES8101067A1 (es) | 1980-12-01 |
MX9202731A (es) | 1992-06-30 |
NL980035I2 (nl) | 1999-03-01 |
IE791629L (en) | 1980-02-25 |
NL980035I1 (nl) | 1999-02-01 |
EP0008391B1 (de) | 1982-02-03 |
FI66372C (fi) | 1984-10-10 |
DE2962051D1 (en) | 1982-03-11 |
CS410191A3 (en) | 1992-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK152496C (da) | Analogifremgangsmaade til fremstilling af i 5- eller 6-stilling med en pyridazinonring substituerede benzimidazoler eller deres fysiologisk acceptable syreadditionssalte | |
DK150510C (da) | Analogifremgangsmaade til fremstilling af substituerede 2-(2-benzimidazolyl)-pyridiner eller terapeutisk acceptable salte deraf | |
DK481879A (da) | Fremgangsmaade til fremstilling af 5-(2-imidazolin-2-yl)-aminopyrimidiner eller syreadditionssalte deraf | |
DK140840B (da) | Analogifremgangsmåde til fremstilling af benzimidazolderivater eller syreadditionssalte deraf. | |
DK15279A (da) | Fremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf | |
DK148260C (da) | Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf | |
DK148117C (da) | Analogifremgangsmaade til fremstilling af 2-(2-thenoylthio)-propionylglycin eller farmakologisk acceptable salte deraf med baser | |
DK294780A (da) | Fremgangsmaade til fremstilling af trans-3-(4-oxo4h-quinazolin-3-yl)-2-propensyrederivater eller salte deraf | |
DK323780A (da) | Fremgangsmaade til fremstilling af substituerede 3-amino-sydnonimider eller farmakologisk acceptable syreadditionssalte deraf | |
DK413783D0 (da) | Fremgangsmade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf | |
DK284779A (da) | Fremgangsmaade til fremstilling af 7-amino-3-(substitueret) thiomethyl-delta3-cephem-4-carxoxylsyre-forbindelser eller derivater i carboxylgruppen deraf eller salte deraf | |
DK146006C (da) | Fremgangsmaade til fremstilling af i 2- og 6-stillingen i phenylringen substituerede 2-phenylamino-2-imidazolin-derivater eller salte deraf | |
DK159427C (da) | Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf | |
DK140695C (da) | Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf | |
DK159079A (da) | Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf | |
DK143703C (da) | Analogifremgangsmaade til fremstilling af 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo(3,2,1-de)=(1,5)naphthyridin-derivater eller syreadditionssalte deraf | |
DK403080A (da) | Fremgangsmaade til fremstilling af 4-thioalkylpyridin- eller -pyrimidin-forbindelser eller syreadditionssalte deraf | |
DK144697C (da) | Analogifremgangsmaade til fremstilling af 3,4-dihydrocarbostyrilderivater eller syreadditionssalte deraf | |
DK160043C (da) | Analogifremgangsmaade til fremstilling af n-alk-2-en-4-yn-yl-benzothienylalkylaminer eller syreadditionssalte deraf | |
DK143752C (da) | Analogifremgangsmaade til fremstilling af pyridobenzodiazepinoner eller farmakologisk acceptable salte deraf | |
DK152501C (da) | Fremgangsmaade til fremstilling af pyrrolooe1,2-aaapyrimidiner eller salte deraf | |
DK152040C (da) | Analogifremgangsmaade til fremstilling af bibenzylderivater eller syreadditionssalte deraf | |
DK145225C (da) | Analogifremgangsmaade til fremstilling af 1-(3-trimethoxyphenoxy-2-hydroxy-propyl)-4-phenyl-piperazinderivater eller syreadditionssalte deraf | |
DK260080A (da) | Fremgangsmaade til fremstilling af 2-amino-alkyl5-phenyl-hexahydro-trans-4a,9b-pyrido (4,3-b)indoler eller syreadditionssalte deraf | |
DK138947B (da) | Analogifremgangsmåde til fremstilling af i 2-stillingen med en pyridylgruppe substituerede imidazolderivater eller pharmaceutisk acceptable salte deraf. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |